Allergy Diagnostics Market Worth $9.8 billion | MarketsandMarkets™

Allergy Diagnostics Market Worth $9.8 billion | MarketsandMarkets™

“The growth of this market is majorly driven by rise in initiatives and investments for allergy research, growth in home care allergy test kits, and establishment of new facilities by hospitals and clinics.”
Allergy Diagnostics Market in terms of revenue was estimated to be worth $5.3 billion in 2024 and is poised to reach $9.8 billion by 2029, growing at a CAGR of 11.0% from 2024 to 2029 according to a new report by MarketsandMarkets™.

 Allergy Diagnostics Market in terms of revenue was estimated to be worth $5.3 billion in 2024 and is poised to reach $9.8 billion by 2029, growing at a CAGR of 11.0% from 2024 to 2029 according to a new report by MarketsandMarkets™.

The growth of this market is majorly driven by rise in initiatives and investments for allergy research, growth in home care allergy test kits, and establishment of new facilities by hospitals and clinics.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=232871701

 

The consumables segment is expected to account for the largest share in 2023.

The Allergy Diagnostics market, by product & service, has been segmented into consumables, instruments, and services. The consumables segment accounted for the largest share of the Allergy Diagnostics market in 2023. This segment is also anticipated to experience significant growth over the projected period. The increasing demand for rapid diagnosis of allergic patients which is driven by increasing number of allergic cases can be attributed for the larger share of this segment during the forecast period.

In Vivo test segment held the largest market share in the Allergy Diagnostics market.

Based on the test type, the Allergy Diagnostics market is segmented into in vivo tests and in vitro tests. In 2023, the in vivo tests segment accounted for the largest share of the Allergy Diagnostics market. The growth of this segment is mainly driven by the growing adoption of various in vivo tests, such as skin prick tests which is considered as the first line of diagnosis for allergy and favorable government support and guidelines.

Inhaled allergy segment held the largest market share in the Allergy Diagnostics market.

Based on the allergen, the Allergy Diagnostics market is segmented into inhaled allergens, food allergens, drug allergens, and other allergens. In 2023, the inhaled allergens segment accounted for the largest share of the Allergy Diagnostics market due to the rising environmental pollution, rising home dust & mites coupled with other factors such as pollen, fungus, mold, and dust, and switching lifestyles, including rise in indoor activities and exposure to indoor allergen.

North America dominates the global Allergy Diagnostics market

Based on the region, the Allergy Diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa. North America market is driven by availability of technologically advanced products and growing research on allergy by companies and government. The Asia Pacific segment is projected to register the highest CAGR during the forecast period. Developing healthcare infrastructure, lifestyle changes and climatic conditions, increased ozone and industrial pollution levels, and the rising demand for quality medical care are some of the major factors driving the growth of this regional market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=232871701

Allergy Diagnostics Market Dynamics:

Drivers:

1.  High incidence and heavy economic burden of allergic diseases

Restraints:

1.  High pricing of allergy diagnostic instruments

Opportunities:

1.  Integration of AI in allergy diagnosis

Challenge:

1.  Shortage of allergists

Key Market Players of Allergy Diagnostics Industry:

Major players in Allergy Diagnostics market include Thermo Fisher Scientific Inc., (US), Siemens Healthineers AG (Germany), Danaher (US), and Canon, Inc. (Japan), Minaris Medical America, Inc. (US).

Breakdown of supply-side primary interviews by company type, designation, and region:

  • By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
  • By Designation: C-level (30%), Director-level (20%), and Others (50%)
  • By Region: North America (36%), Asia- Pacific (27%), Europe (25%), and Latin America- (7%) and MEA-(5%)

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=232871701

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.prnewswire.com/news-releases/allergy-diagnostics-market-worth-9-8-billion–marketsandmarkets-302123057.html